Guided by our corporate philosophy of “contributing to the health of humankind through the development of revolutionary biotechnologies such as gene therapy,” and from the perspective of enhancing our medium- to long-term corporate value, Takara Bio Group addresses a wide range of social issues related to sustainability—including health—through its business activities, and aims to achieve both “the realization of a sustainable society” and “the sustainable growth of Takara Bio Group.”
As part of this effort, we will identify materialities (key issues) and promote sustainability management in order to contribute to solving social challenges through collaboration with stakeholders and partnership with the Takara Holdings Group.
In promoting sustainability activities, Takara Bio Group has identified nine materialities, taking into account their impact on the Group and the expectations of stakeholders.
Going forward, we will address social challenges with a focus on these nine materialities, aiming to achieve both the realization of a sustainable society and the sustainable growth of Takara Bio Group.
|
|
|
|---|
|
|
|
|---|
|
|
|
|---|
|
|
|
|---|
|
|
|
|---|
|
|
|
|---|
|
|
|
Takara Bio Group Procurement Policy |
|---|
|
|
|
|---|
|
Value Creation in
|
|
|---|
The Takara Bio Group has established the Takara Bio Group Sustainability Promotion Committee, chaired by the President of Takara Bio, to promote sustainability activities and drive initiatives related to each materiality.
For more information on the Takara Holdings Group's sustainability activities, please visit the Takara Holdings website.